A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies

Clinical trial NCT06690281 · WITHDRAWN

Trial details

NCT number: NCT06690281
Sponsor: National Cancer Institute (NCI)
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Carcinoma Pancreatic Cancer Hepatocellular Cancer Cholangiocarcinoma Duodenal Cancer Colorectal Cancer Small Bowel Cancer Metastatic Cancers

Start date: 2025-09-09
Primary completion: 2025-09-09
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.